Inspiring, Powerful, Top-notch. Dr. Asifa Akhtar receives 2021 Leibniz Prize

Dr Asifa Akhtar has been selected to receive the most distinguished prize in Germany: The Leibniz Prize! The award has acknowledged and estimated her huge breakthrough work in the field of Cell-Biology and it’s mechanisms of epigenetic gene regulation, the prize consists of a €2.5 million research funding.

With her Freiburg team, Asifa Akhtar is investigating epigenetic mechanisms that act in addition to the genes in the cells – and thus help determine which and how genetic information is used. One focus is on molecules that change the chromatin, i.e., the packaging of the DNA, and thus play an important role in controlling gene activity. “I feel incredibly honored to receive this prize. Above all, I am grateful to my former and current lab members; their dedication and hard work made this award possible,” said Asifa Akhtar.

Dr Asifa Akhtar

The DFG substantiate its decision, among other things, with Asifa Akhtar’s “groundbreaking contribution to the understanding of X chromosome regulation, also known as dosage compensation.” Since males and females differ in the number of their X chromosomes, this mechanism ensures that both sexes shed the same amount of genes encoded on the X chromosomes. If this does not happen, severe cellular defects can occur. What are the critical molecular factors achieving dosage compensation? How do they interact, and do they also have additional functions? Studies by Asifa Akhtar’s laboratory have provided important answers to these questions and clarified the essential basics of regulating the X chromosome and autosomes.

The biologist and here team elucidated the molecular mechanism that controls the different functions of the epigenetic regulator MOF (males-absent on the first protein) on the X chromosome and the autosomes. This histone acetyltransferase facilitates the accessibility of genetic material by modifying histones, which are the proteins on which the DNA is wrapped around within the nucleus. Furthermore, the team discovered that this epigenetic regulator is also involved in other control processes in the genome. The DFG acknowledges that these findings have been “fundamental for understanding developmental and pathological processes as to be known in cancer”.

The broader importance and clinical relevance of the basic research carried out in the Akhtar lab was brought to the fore by the discovery of a human syndrome caused by a mutation in an epigenetic regulator closely related to MOF and another one of the lab’s main proteins of interest. The later termed “Basilicata-Akhtar syndrome” is marked by severe developmental delay and neurological dysfunction. The lab’s groundbreaking work on the molecular characterization of this human syndrome paves the way for better understanding and eventually alleviating the condition. 

Dr. Asif was born in Karachi, Pakistan and she presides the Max Planck Institute of Immunobiology and Epigenetics as its vice president, the first International female to have this position. She is among 10 other scientists who will be awarded this prize in 2021 in an expected virtual ceremony.

Our heartfelt congratulations are presented to her. She is an inspiration for so many people pursuing science both in Pakistan and Germany. We look forward to her contribution to science.

19 thoughts on “Inspiring, Powerful, Top-notch. Dr. Asifa Akhtar receives 2021 Leibniz Prize

  1. It’s truly very complex in this active life to listen news on Television,
    thus I simply use world wide web for that reason, and get the latest news.

  2. Hello there! I could have sworn I’ve been to this blog before but after checking through some
    of the post I realized it’s new to me. Anyhow, I’m definitely
    happy I found it and I’ll be book-marking and checking back frequently!

  3. Prawdziwy z Ciebie talent i mistrz pióra z ogromną łatwością przekładasz myśli na słowa… trzymaj tak dalej, dbaj i pięlęgnuj swego bloga… Skąd czerpiesz tak ciekawe inspiracje ?

  4. Hello there, just became aware of your blog through Google, and found that it is truly
    informative. I am going to watch out for brussels.
    I’ll appreciate if you continue this in future. A lot of people will be benefited from your writing.

  5. Do you have a spam issue on this site; I also am a blogger, and I was wondering your situation; we have created some nice methods and we
    are looking to exchange techniques with others, please
    shoot me an email if interested.

  6. Admiring the time and effort you put into your website and in depth information you provide.
    It’s nice to come across a blog every once in a while that isn’t the same out of date rehashed information. Great read!
    I’ve bookmarked your site and I’m including your RSS feeds to my Google account.

  7. Oh my goodness! Awesome article dude! Thanks, However I am encountering difficulties with your RSS.
    I don’t understand the reason why I am unable to join it.
    Is there anybody getting the same RSS issues? Anyone that knows the solution will you kindly
    respond? Thanx!!

  8. I’m really enjoying the theme/design of your site. Do you
    ever run into any internet browser compatibility problems?
    A few of my blog readers have complained about my site not operating correctly in Explorer but looks great in Firefox.
    Do you have any suggestions to help fix this problem?

  9. I read this paragraph completely regarding the resemblance
    of newest and earlier technologies, it’s awesome article.

  10. Not too long ago, I did not give a lot of thought to making comments on blog page articles and have placed feedback even much less. Reading by way of your pleasant article, will support me to do so sometimes.

  11. Wow in truth a huge post. I like this.I just passed this onto a colleague who was doing a little research on that. And he actually bought me lunch because I found it for him. Overall, Lots of great information and inspiration, both of which we all need!

  12. Hi, Neat post. There’s an issue with your site in web explorer, might test this?
    IE still is the market chief and a good part of other folks will pass
    over your wonderful writing due to this problem.

Comments are closed.